Edition:
India

Pacific Biosciences of California Inc (PACB.OQ)

PACB.OQ on NASDAQ Stock Exchange Global Select Market

8.91USD
1:30am IST
Change (% chg)

$0.41 (+4.82%)
Prev Close
$8.50
Open
$8.11
Day's High
$8.93
Day's Low
$8.08
Volume
1,385,439
Avg. Vol
699,033
52-wk High
$8.93
52-wk Low
$2.20

Latest Key Developments (Source: Significant Developments)

Pacific Biosciences Of California Inc Announces Pricing Of Public Offering Of Common Stock
Wednesday, 12 Aug 2020 

Aug 11 (Reuters) - Pacific Biosciences of California Inc ::PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.PACIFIC BIOSCIENCES OF CALIFORNIA -PRICED PREVIOUSLY ANNOUNCED UNDERWRITTEN PUBLIC OFFERING OF 19,430,000 SHARES AT PRICE TO PUBLIC OF $4.47 PER SHARE.  Full Article

Pacific Biosciences Of California Posts Qtrly Loss Per Share Of $0.15
Tuesday, 4 Aug 2020 

Aug 3 (Reuters) - Pacific Biosciences of California Inc ::PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES SECOND QUARTER 2020 FINANCIAL RESULTS.Q2 REVENUE $17.1 MILLION VERSUS REFINITIV IBES ESTIMATE OF $13.7 MILLION.QTRLY LOSS PER SHARE $0.15.  Full Article

PGI Files Patent Infringement Complaint Against Pacbio
Wednesday, 2 Oct 2019 

Oct 1 (Reuters) - PGI::PGI FILES PATENT INFRINGEMENT COMPLAINT AGAINST PACBIO.PERSONAL GENOMICS TAIWAN - COMPLAINT ASSERTS PACBIO'S SEQUEL AND SEQUEL II INFRINGE ONE OR MORE CLAIMS OF PATENT OWNED BY PGI.  Full Article

Pacific Biosciences Of California Reports Qtrly Loss Per Share $0.20
Saturday, 4 May 2019 

May 3 (Reuters) - Pacific Biosciences of California Inc ::PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES FIRST QUARTER 2019 FINANCIAL RESULTS.GIVEN PENDING MERGER WITH ILLUMINA, WILL NOT BE HOSTING CONFERENCE CALL TO DISCUSS ITS RESULTS FOR Q1.QTRLY LOSS PER SHARE $0.20.Q1 EARNINGS PER SHARE VIEW $-0.15 -- REFINITIV IBES DATA.QTRLY TOTAL REVENUE $16.4 MILLION VERSUS $19.4 MILLION.Q1 REVENUE VIEW $21.6 MILLION -- REFINITIV IBES DATA.PACIFIC BIOSCIENCES OF CALIFORNIA - GIVEN PENDING MERGER WITH ILLUMINA, ALSO DOES NOT EXPECT TO HOST CONF CALL TO DISCUSS ITS RESULTS FOR FUTURE QUARTERS.  Full Article

Oxford Nanopore Prevails Against PacBio In Final Decision By U.S. Court Of Appeal
Tuesday, 12 Feb 2019 

Feb 12 (Reuters) - Oxford Nanopore::OXFORD NANOPORE - U.S. COURT OF APPEALS FOR FEDERAL CIRCUIT TODAY UPHELD DECISION OF INTERNATIONAL TRADE COMMISSION (ITC) IN FAVOUR OF OXFORD NANOPORE.  Full Article